Tenet Healthcare Corp.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $21.31B | $20.68B | $20.56B | $19.17B | $19.49B | $17.64B | $18.48B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | $3.51B | $5.96B | $2.51B | $2.33B | $2.87B | $1.99B | $1.54B |
| Operating Margin | — | 16.5% | 28.8% | 12.2% | 12.2% | 14.7% | 11.3% | 8.3% |
| Interest Expense | — | — | — | $901.0M | $890.0M | $923.0M | $1.00B | $985.0M |
| Pretax Income | — | $2.80B | $5.25B | $1.62B | $1.35B | $1.89B | $671.0M | $320.0M |
| Income Tax Expense | — | $433.0M | $1.18B | $306.0M | $344.0M | $411.0M | $-97.0M | $160.0M |
| Net Income | — | $2.37B | $4.06B | $1.31B | $1.00B | $1.48B | $768.0M | $171.0M |
| Net Margin | — | 11.1% | 19.7% | 6.4% | 5.2% | 7.6% | 4.4% | 0.9% |
| EPS (Basic) | — | $15.61 | $33.02 | $6.01 | $3.84 | $8.55 | $3.80 | $-2.08 |
| EPS (Diluted) | — | $15.49 | $32.70 | $5.71 | $3.79 | $8.42 | $3.75 | $-2.08 |
| Shares Outstanding (Basic) | 87.0M | 90.2M | 96.9M | 101.6M | 106.9M | 106.8M | 105.0M | 103.4M |
| Shares Outstanding (Diluted) | 87.0M | 90.8M | 97.9M | 104.8M | 110.5M | 108.6M | 106.3M | 103.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |